142 related articles for article (PubMed ID: 33221091)
1. Need for Systematic Magnetic Resonance Imaging Interpretation and Reporting after Partial Prostate Gland Ablation.
Hu JC; Basourakos SP; Futterer J
Eur Urol; 2021 Feb; 79(2):167-169. PubMed ID: 33221091
[TBL] [Abstract][Full Text] [Related]
2. Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus.
Lebastchi AH; George AK; Polascik TJ; Coleman J; de la Rosette J; Turkbey B; Wood BJ; Gorin MA; Sidana A; Ghai S; Tay KJ; Ward JF; Sanchez-Salas R; Muller BG; Malavaud B; Mozer P; Crouzet S; Choyke PL; Ukimura O; Rastinehad AR; Pinto PA
Eur Urol; 2020 Sep; 78(3):371-378. PubMed ID: 32532513
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer: state of the art imaging and focal treatment.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Clin Radiol; 2017 Aug; 72(8):665-679. PubMed ID: 28385253
[TBL] [Abstract][Full Text] [Related]
4. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric magnetic resonance imaging and active surveillance: How to better select insignificant prostate cancer?
Porpiglia F; Cantiello F; De Luca S; De Pascale A; Manfredi M; Mele F; Bollito E; Cirillo S; Damiano R; Russo F
Int J Urol; 2016 Sep; 23(9):752-7. PubMed ID: 27277398
[TBL] [Abstract][Full Text] [Related]
6. The Use of Magnetic Resonance Imaging to Predict Oncological Control Among Candidates for Focal Ablation of Prostate Cancer.
Kenigsberg AP; Llukani E; Deng FM; Melamed J; Zhou M; Lepor H
Urology; 2018 Feb; 112():121-125. PubMed ID: 29061480
[TBL] [Abstract][Full Text] [Related]
7. Candidate selection for quadrant-based focal ablation through a combination of diffusion-weighted magnetic resonance imaging and prostate biopsy.
Matsuoka Y; Numao N; Saito K; Tanaka H; Kumagai J; Yoshida S; Ishioka J; Koga F; Masuda H; Kawakami S; Fujii Y; Kihara K
BJU Int; 2016 Jan; 117(1):94-101. PubMed ID: 25124332
[TBL] [Abstract][Full Text] [Related]
8. Interpreting Prostate Multiparametric Magnetic Resonance Imaging: Urologists' Guide Including Prostate Imaging Reporting and Data System.
Christidis D; McGrath S; Leaney B; O'Sullivan R; Lawrentschuk N
Urology; 2018 Jan; 111():136-138. PubMed ID: 28823635
[TBL] [Abstract][Full Text] [Related]
9. Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer.
Choi YH; Yu JW; Kang MY; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
World J Urol; 2019 Oct; 37(10):2129-2135. PubMed ID: 30603783
[TBL] [Abstract][Full Text] [Related]
10. Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.
Gibson E; Bauman GS; Romagnoli C; Cool DW; Bastian-Jordan M; Kassam Z; Gaed M; Moussa M; Gómez JA; Pautler SE; Chin JL; Crukley C; Haider MA; Fenster A; Ward AD
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):188-96. PubMed ID: 27375167
[TBL] [Abstract][Full Text] [Related]
11. Comparative Analysis of Partial Gland Ablation and Radical Prostatectomy to Treat Low and Intermediate Risk Prostate Cancer: Oncologic and Functional Outcomes.
Garcia-Barreras S; Sanchez-Salas R; Sivaraman A; Barret E; Secin F; Nunes-Silva I; Linares-Espinós E; Rozet F; Galiano M; Cathelineau X
J Urol; 2018 Jan; 199(1):140-146. PubMed ID: 28823768
[TBL] [Abstract][Full Text] [Related]
12. SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer.
Gross MD; Sedrakyan A; Bianco FJ; Carroll PR; Daskivich TJ; Eggener SE; Ehdaie B; Fisher B; Gorin MA; Hunt B; Jiang H; Klein EA; Marinac-Dabic D; Montgomery JS; Polascik TJ; Priester AM; Rastinehad AR; Viviano CJ; Wysock JS; Hu JC
J Urol; 2019 Nov; 202(5):952-958. PubMed ID: 31144591
[TBL] [Abstract][Full Text] [Related]
13. Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer.
Orczyk C; Barratt D; Brew-Graves C; Peng Hu Y; Freeman A; McCartan N; Potyka I; Ramachandran N; Rodell R; Williams NR; Emberton M; Ahmed HU
J Urol; 2021 Apr; 205(4):1090-1099. PubMed ID: 33315505
[TBL] [Abstract][Full Text] [Related]
14. A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy.
Salmasi A; Said J; Shindel AW; Khoshnoodi P; Felker ER; Sisk AE; Grogan T; McCullough D; Bennett J; Bailey H; Lawrence HJ; Elashoff DA; Marks LS; Raman SS; Febbo PG; Reiter RE
J Urol; 2018 Sep; 200(3):564-572. PubMed ID: 29524506
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional localization and targeting of prostate cancer foci with imaging and histopathologic correlation: establishing a multidisciplinary team for quality improvement.
Aminsharifi A; Gupta RT; Huang J; Polascik TJ
Curr Opin Urol; 2018 Nov; 28(6):506-511. PubMed ID: 30239416
[TBL] [Abstract][Full Text] [Related]
16. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-analysis.
Woo S; Suh CH; Kim SY; Cho JY; Kim SH
Eur Urol; 2017 Aug; 72(2):177-188. PubMed ID: 28196723
[TBL] [Abstract][Full Text] [Related]
18. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP
Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971
[TBL] [Abstract][Full Text] [Related]
19. Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with
Sobol I; Zaid HB; Haloi R; Mynderse LA; Froemming AT; Lowe VJ; Davis BJ; Kwon ED; Karnes RJ
J Urol; 2017 Jan; 197(1):129-134. PubMed ID: 27449262
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric MR imaging of the Prostate: Interpretation Including Prostate Imaging Reporting and Data System Version 2.
Furlan A; Borhani AA; Westphalen AC
Radiol Clin North Am; 2018 Mar; 56(2):223-238. PubMed ID: 29420978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
